Vimeo
LinkedIn
Instagram
Share |

invest

December 10, 2020

We believe that vaccine prospects are likely to make 2021 a year of global economic recovery. While markets have priced in a fair amount of the good news, more gains seem possible as corporate profits rebound and central banks remain on hold.

We believe that vaccine prospects are likely to make 2021 a year of global economic recovery. While markets have priced in a fair amount of the good news, more gains seem possible as corporate profits rebound and central banks remain on hold.

With the world in the early post-recession recovery phase of the business cycle, our medium-term outlook for economies and corporate earnings is positive. We believe that 2021 will feature an extended period of low-inflation, low-interest rate growth that favours equities over bonds.

November 12, 2020

Vertical farming is being planted as the future of agriculture and the blossoming sector’s long-term growth could be a good fit for family investors and their patient capital.

Vertical farming is being planted as the future of agriculture and the blossoming sector’s long-term growth could be a good fit for family investors and their patient capital.

Issues surrounding the increasing population of the world combined with water scarcity in a changing climate and the security of food and supply chains exposed by the coronavirus pandemic have all seeded minds on the possibilities of vertical farming.

November 9, 2020

The Covid-19 crisis obviously caught us off guard by the speed with which it spread and the force of the virus. We had to deal with it by adapting to a new environment and new ways of working. Countries in Europe are now learning to live with the virus, and its impact is not behind us by any means, and the coming months could be crucial for our industry.

Covid-19 has created challenges for performance and fundraising in the short term, but the longer-term prospects are strong and the capital shift to alternatives will continue, says Amundi Asset Management.

October 26, 2020

The carbon emission obligations established under the monumental Paris Agreement of 2015 have gone largely unfulfilled and are at risk of failing. Sensing the urgency to attempt to rectify the situation, countries are now racing to implement mandates for the development of renewable energy assets and the requisite grid enabling infrastructure. These mandates are generating demand for renewable energy infrastructure which, in turn, may lead to an opportunity for investors.

The carbon emission obligations established under the monumental Paris Agreement of 2015 have gone largely unfulfilled and are at risk of failing. Sensing the urgency to attempt to rectify the situation, countries are now racing to implement mandates for the development of renewable energy assets and the requisite grid enabling infrastructure. These mandates are generating demand for renewable energy infrastructure which, in turn, may lead to an opportunity for investors.

October 8, 2020

Whatever one’s outlook, there have been times in 2020 when the markets seemed to echo one’s innermost thoughts, and times when we shout out like Falstaff, that the whole world has gone mad. The bulls and the bears have had their time in the sun, and their time on the dark face of the moon—what follows is a digested diary of our journey through the year 2020 so far.

September 10, 2020

Could a vaccine change market leadership? When will enough doses of FDA-approved Covid-19 vaccine(s) to inoculate 25 million people be distributed in the US? The superforecasters of the Good Judgement Project believe there is a 93% probability we will have an FDA-approved vaccine in a year, and enough of it to inoculate 25 million people in the US. This is up from just 20% in the dark days of April.

Could a vaccine change market leadership? When will enough doses of FDA-approved Covid-19 vaccine(s) to inoculate 25 million people be distributed in the US? The superforecasters of the Good Judgement Project believe there is a 93% probability we will have an FDA-approved vaccine in a year, and enough of it to inoculate 25 million people in the US. This is up from just 20% in the dark days of April.

May 31, 2020

LXRepair will present to global investors its new approach to personalised cancer therapies at the Campden Wealth MedTech Investing Europe Conference in September 2020.

LXRepair will present to global investors its new approach to personalised cancer therapies at the Campden Wealth MedTech Investing Europe Conference in September 2020.

The French medtech company is pioneering the development of functional comprehensive DNA repair and DDR assay and has researched the science behind DNA repair mechanisms and in vitro diagnostics for cancer over the past 25 years.

May 27, 2020

The European Leveraged Loans market—like other credit markets—suffered from a sudden and indiscriminate market price decrease at the beginning of the Covid-19 crisis in March, mainly resulting from lack of liquidity across all sub-investment markets and concerns about future rating downgrades and increased probability of defaults.

The European Leveraged Loans market—like other credit markets—suffered from a sudden and indiscriminate market price decrease at the beginning of the Covid-19 crisis in March, mainly resulting from lack of liquidity across all sub-investment markets and concerns about future rating downgrades and increased probability of defaults.

April 24, 2020

Campden Wealth is rising to the challenge of family networking in the age of the coronavirus by calling for exceptional management funds to join its exclusive Alternative Fund Manager Event online on the new date of 14 May.

Campden Wealth is rising to the challenge of family networking in the age of the coronavirus by calling for exceptional management funds to join its exclusive Alternative Fund Manager Event online on the new date of 14 May.

Only five limited fund managers will be permitted to present to Campden’s global network of ultra-high net worth family offices and private investors.

Click here >>
Close